ATE515699T1 - Verwendung von adiponectin als marker in der vorhersage post-operativer infektion - Google Patents
Verwendung von adiponectin als marker in der vorhersage post-operativer infektionInfo
- Publication number
- ATE515699T1 ATE515699T1 AT05727482T AT05727482T ATE515699T1 AT E515699 T1 ATE515699 T1 AT E515699T1 AT 05727482 T AT05727482 T AT 05727482T AT 05727482 T AT05727482 T AT 05727482T AT E515699 T1 ATE515699 T1 AT E515699T1
- Authority
- AT
- Austria
- Prior art keywords
- adiponectin
- marker
- prediction
- post
- operative infection
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ecology (AREA)
- Biophysics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004134824 | 2004-03-31 | ||
JP2004134823 | 2004-03-31 | ||
PCT/JP2005/006395 WO2005094188A1 (ja) | 2004-03-31 | 2005-03-31 | 侵襲管理方法及びアディポネクチンの利用 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE515699T1 true ATE515699T1 (de) | 2011-07-15 |
Family
ID=35064193
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05727482T ATE515699T1 (de) | 2004-03-31 | 2005-03-31 | Verwendung von adiponectin als marker in der vorhersage post-operativer infektion |
AT10185392T ATE544467T1 (de) | 2004-03-31 | 2005-03-31 | Adiponectin als endotoxin neutralisierendes agenz |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT10185392T ATE544467T1 (de) | 2004-03-31 | 2005-03-31 | Adiponectin als endotoxin neutralisierendes agenz |
Country Status (7)
Country | Link |
---|---|
US (2) | US20080139468A1 (de) |
EP (2) | EP2279745B1 (de) |
JP (2) | JP4771940B2 (de) |
KR (2) | KR101223355B1 (de) |
CN (1) | CN1969187A (de) |
AT (2) | ATE515699T1 (de) |
ES (1) | ES2365923T3 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2279745B1 (de) | 2004-03-31 | 2012-02-08 | Kazuhisa Maeda | Adiponectin als Endotoxin neutralisierendes Agenz |
JP5432567B2 (ja) * | 2008-04-16 | 2014-03-05 | 花王株式会社 | アディポネクチン分泌調節剤の評価又は選択方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4237502A1 (de) * | 1992-11-06 | 1994-05-11 | Biometec Ges Fuer Bio Medizini | Arzneimittel enthaltend Antiidiotyp-Antikörper gegen Anti-CD14-Antikörper |
JP3018186B1 (ja) | 1999-03-09 | 2000-03-13 | 大阪大学長 | 抗炎症剤、単球系細胞の増殖抑制剤 |
CA2383136C (en) * | 2000-01-14 | 2012-09-18 | Genset S.A. | Obg3 globular head and uses thereof for decreasing body mass |
DE60239622D1 (de) * | 2001-08-17 | 2011-05-12 | Fujirebio Kk | Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel |
EP1458758A2 (de) * | 2001-12-21 | 2004-09-22 | Maxygen Aps | Adiponectin-fragmente und -konjugate |
CA2473781A1 (en) * | 2002-01-18 | 2003-07-31 | Protemix Corporation Limited | Glycoisoforms of adiponectin and uses thereof |
AU2003244237A1 (en) * | 2002-09-05 | 2004-03-29 | Komed Co., Ltd. | Monoclonal antibody against adiponectin, preparation method and use thereof |
EP2279745B1 (de) | 2004-03-31 | 2012-02-08 | Kazuhisa Maeda | Adiponectin als Endotoxin neutralisierendes Agenz |
-
2005
- 2005-03-31 EP EP10185392A patent/EP2279745B1/de not_active Not-in-force
- 2005-03-31 AT AT05727482T patent/ATE515699T1/de not_active IP Right Cessation
- 2005-03-31 EP EP05727482A patent/EP1744160B1/de active Active
- 2005-03-31 AT AT10185392T patent/ATE544467T1/de active
- 2005-03-31 ES ES05727482T patent/ES2365923T3/es active Active
- 2005-03-31 KR KR1020067022439A patent/KR101223355B1/ko not_active IP Right Cessation
- 2005-03-31 KR KR1020117024465A patent/KR20110128941A/ko not_active Application Discontinuation
- 2005-03-31 US US11/547,169 patent/US20080139468A1/en not_active Abandoned
- 2005-03-31 JP JP2006511829A patent/JP4771940B2/ja active Active
- 2005-03-31 CN CNA2005800177180A patent/CN1969187A/zh active Pending
-
2011
- 2011-01-11 JP JP2011003377A patent/JP2011121959A/ja active Pending
-
2013
- 2013-05-09 US US13/890,697 patent/US9341634B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2011121959A (ja) | 2011-06-23 |
KR20110128941A (ko) | 2011-11-30 |
ATE544467T1 (de) | 2012-02-15 |
JPWO2005094188A1 (ja) | 2008-02-14 |
EP1744160A4 (de) | 2008-05-21 |
JP4771940B2 (ja) | 2011-09-14 |
EP2279745A2 (de) | 2011-02-02 |
CN1969187A (zh) | 2007-05-23 |
EP1744160B1 (de) | 2011-07-06 |
WO2005094188A2 (ja) | 2005-10-13 |
EP1744160A2 (de) | 2007-01-17 |
EP2279745B1 (de) | 2012-02-08 |
KR20070026485A (ko) | 2007-03-08 |
ES2365923T3 (es) | 2011-10-13 |
KR101223355B1 (ko) | 2013-01-16 |
EP2279745A3 (de) | 2011-02-16 |
US20130302833A1 (en) | 2013-11-14 |
US9341634B2 (en) | 2016-05-17 |
WO2005094188A3 (ja) | 2005-12-08 |
US20080139468A1 (en) | 2008-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE477249T1 (de) | Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes | |
ATE415662T1 (de) | Bestimmung der tatsächlichen zeit, die ein prozessor bei der ausführung eines codeteiles aufwendet | |
ATE428417T1 (de) | Derivate von piperidinylalkylcarbamaten, herstellungsverfahren davon und verwendung derselben als faah-enzym-inhibitoren | |
DE602005016800D1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
DE602005008325D1 (de) | Quantifizierung von Enzymaktivität mittels planarer Wellenleiter | |
ATE529042T1 (de) | Verfahren zur quantifizierung des herztodrisikos unter verwendung von übungsinduzierten herzfrequenzvariabilitätsmetriken | |
TW200722753A (en) | Meter having multi-level user interface | |
ATE381334T1 (de) | 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren | |
DE502005006470D1 (de) | Verwendung von sulfonylharnstoffen | |
ATE523053T1 (de) | Verfahren zur erhöhung der positionsverfügbarkeit | |
DE50214648D1 (de) | Messung der konzentration von substanzen in lebenden organismen mittels mikrodialyse | |
DK1824401T3 (da) | Knogleplade med i forvejen monterede tilspidsede organer med boret føring | |
ATE546044T1 (de) | Verwendung von alkylcarbonsäureamiden als penetrationsförderer | |
ATE486878T1 (de) | Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin | |
DE60235866D1 (de) | Verwendung von speziellen Aminosilikonen zur Nachbehandlung in der direkten oder oxidativen Färbung von Keratinfasern | |
DE602005017135D1 (de) | Neue verwendung von pde5-hemmern | |
DE602005020643D1 (de) | Verfahren zur aktivierung von nkt-zellen | |
DE60325299D1 (de) | pontanhalleffekt und Datenschreibe- leseverfahren unter Verwendung eines solchen | |
NO20065907L (no) | Nye tetrahydropyridotiofener | |
ATE495243T1 (de) | Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung | |
CY1111853T1 (el) | Θεση δεσμευσης υψηλης συγγενειας στον hgfr και μεθοδοι ταυτοποιησης ανταγωνιστων αυτου | |
ATE515699T1 (de) | Verwendung von adiponectin als marker in der vorhersage post-operativer infektion | |
DE602005007818D1 (de) | Analysevorrichtung unter Verwendung von abgeschwächter Totalreflektion | |
DE602004006362D1 (de) | Ladebrückecharnier mit konstantem Radius | |
ATE476986T1 (de) | Verfahren zur steigerung der lymphatischen funktion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |